Transition Support Award CSF Chris Gale
Lead Research Organisation:
Imperial College London
Department Name: School of Public Health
Abstract
1 in 11 UK babies are born prematurely; many of these need neonatal care that involves medical decisions about every part of a baby's care. Many babies who require neonatal care have medical and neurological problems that affect them throughout their lives; these may be influenced by decisions made during their neonatal stay.
The ideal way to work out which clinical decision is the best is through a randomised trial. Here each baby has an equal chance of being given each treatment option and this is chosen by chance, like tossing a coin. By including lots of babies we can work out which treatment option works best. Unfortunately, randomised trials are often very expensive and burdensome. As a result, only a small number of neonatal treatment options have been tested in randomised trials and so most decisions are only educated guesses.
I want to make randomised clinical trials cheaper and easier so all day-to-day neonatal decisions can be based on the best research - randomised clinical trials. I plan to do this is by getting rid of one very expensive part, data collection, by getting all the information straight from a baby's electronic health record (EHR), a computerised version of the medical notes. Information from these EHR systems is already used for lots of purposes, I want to use it for randomised trials to make them much cheaper and easier so more can be carried out, more simply and easily.
We have already completed the following work to show that large simple neonatal trials built into EHR systems are feasible:
1. We have worked with doctors, nurses, parents, patients and researchers to determine what the most important "outcomes" for large simple neonatal trials are. An "outcome" is a result of a trial, like whether a baby needs oxygen at home
2. We have shown it is possible to carry out a moderately large, novel and pioneering trial embedded within the neonatal EHR, and have measured how accurate, simple and inexpensive this is
3. We have involved parents, doctors and nurse to make taking consent for large simple neonatal trials easier and more straightforward, and have shown that this is acceptable
4. We have worked with parents to develop a system to give parents information from the EHR about their baby rapidly and easily through a mobile app (the BUDS app)
This completed work has shown that large simple neonatal trials are feasible, but also identified some problems - particularly around how accurate and complete some information is. This work has also shown that another way to make neonatal randomised trials easier and simpler is by using 'cluster trials' where instead of the treatment each baby receives being decided by chance, the treatment a whole neonatal unit uses is decided by chance.
We want to build on this work to see if we can make neonatal EHR data better by involving parents, and to see whether large simple 'cluster trials' are possible using the neonatal EHR system. We plan to do this by:
1. Testing to see whether giving parents information from the EHR about their baby rapidly and easily through a mobile app leads to more complete and accurate data in the neonatal EHR system
2. Looking at how accurate and complete neonatal EHR data need to be for different large simple neonatal EHR trials and cluster trials to work
3. Showing that we can measure the 'outcomes' that parents, patients, doctors, nurses and researchers identified as important from neonatal EHR data
Finally we want to make sure that knowledge from large simple neonatal trials can be quickly and effectively communicated across the NHS to improve the way babies are looked after, so we will learn from the successes and mistakes of other health systems in the USA that already do this using EHR systems. We will work with neonatal doctors, nurses and researchers and with EHR companies to find the best way of doing this in the NHS.
The ideal way to work out which clinical decision is the best is through a randomised trial. Here each baby has an equal chance of being given each treatment option and this is chosen by chance, like tossing a coin. By including lots of babies we can work out which treatment option works best. Unfortunately, randomised trials are often very expensive and burdensome. As a result, only a small number of neonatal treatment options have been tested in randomised trials and so most decisions are only educated guesses.
I want to make randomised clinical trials cheaper and easier so all day-to-day neonatal decisions can be based on the best research - randomised clinical trials. I plan to do this is by getting rid of one very expensive part, data collection, by getting all the information straight from a baby's electronic health record (EHR), a computerised version of the medical notes. Information from these EHR systems is already used for lots of purposes, I want to use it for randomised trials to make them much cheaper and easier so more can be carried out, more simply and easily.
We have already completed the following work to show that large simple neonatal trials built into EHR systems are feasible:
1. We have worked with doctors, nurses, parents, patients and researchers to determine what the most important "outcomes" for large simple neonatal trials are. An "outcome" is a result of a trial, like whether a baby needs oxygen at home
2. We have shown it is possible to carry out a moderately large, novel and pioneering trial embedded within the neonatal EHR, and have measured how accurate, simple and inexpensive this is
3. We have involved parents, doctors and nurse to make taking consent for large simple neonatal trials easier and more straightforward, and have shown that this is acceptable
4. We have worked with parents to develop a system to give parents information from the EHR about their baby rapidly and easily through a mobile app (the BUDS app)
This completed work has shown that large simple neonatal trials are feasible, but also identified some problems - particularly around how accurate and complete some information is. This work has also shown that another way to make neonatal randomised trials easier and simpler is by using 'cluster trials' where instead of the treatment each baby receives being decided by chance, the treatment a whole neonatal unit uses is decided by chance.
We want to build on this work to see if we can make neonatal EHR data better by involving parents, and to see whether large simple 'cluster trials' are possible using the neonatal EHR system. We plan to do this by:
1. Testing to see whether giving parents information from the EHR about their baby rapidly and easily through a mobile app leads to more complete and accurate data in the neonatal EHR system
2. Looking at how accurate and complete neonatal EHR data need to be for different large simple neonatal EHR trials and cluster trials to work
3. Showing that we can measure the 'outcomes' that parents, patients, doctors, nurses and researchers identified as important from neonatal EHR data
Finally we want to make sure that knowledge from large simple neonatal trials can be quickly and effectively communicated across the NHS to improve the way babies are looked after, so we will learn from the successes and mistakes of other health systems in the USA that already do this using EHR systems. We will work with neonatal doctors, nurses and researchers and with EHR companies to find the best way of doing this in the NHS.
Technical Summary
Aims of Transitional Support Award
1. Implement the BUDS app to allow parents near real-time access to their baby's data and quantify impact on routinely recorded EHR data quality
I. Continue app development
- Methods: Co-design, linkage with EHR data, implementation in London neonatal units
II. Evaluate impact on EHR data quality
- Methods: Pre/post evaluation of parent satisfaction and EHR data completeness/accuracy
III. Evaluate feasibility acceptability of BUDS app
- Methods: Structured questionnaires and qualitative interviews
2. Extract and analyse data to underpin a range of neonatal EHR-embedded trials
I. Calculate underpinning data e.g. intra-cluster coefficients/missing data proportions for core trial data items
- Methods: Analyses of EHR data in the National Neonatal Research Database (NNRD)
II. Model impact of degrees of missing/inaccurate data on individually/cluster randomised neonatal trials
- Methods: Simulate multiple individually/cluster randomised neonatal trials using NNRD data; trial effect sizes/outcomes based on published trials
- Outcomes: rates of missing/inaccurate data required to alter modelled trial findings
3. Validate the extraction of core neonatal outcomes in the NNRD
I. Identify core neonatal outcomes (prioritised earlier in the fellowship) in the NNRD; formalise extraction; validate against published and existing trial data
- Methods: Analyses NNRD data; systematic review of reported rates in similar high resource settings and large neonatal trials
4. Realise learning from research placement in Boston Veteran's Affairs and Children's Hospitals
I. Disseminate qualitative data from research placement
II. Consensus meetings to identify acceptable integration of "Learning Healthcare System" approach into NHS neonatal care
1. Implement the BUDS app to allow parents near real-time access to their baby's data and quantify impact on routinely recorded EHR data quality
I. Continue app development
- Methods: Co-design, linkage with EHR data, implementation in London neonatal units
II. Evaluate impact on EHR data quality
- Methods: Pre/post evaluation of parent satisfaction and EHR data completeness/accuracy
III. Evaluate feasibility acceptability of BUDS app
- Methods: Structured questionnaires and qualitative interviews
2. Extract and analyse data to underpin a range of neonatal EHR-embedded trials
I. Calculate underpinning data e.g. intra-cluster coefficients/missing data proportions for core trial data items
- Methods: Analyses of EHR data in the National Neonatal Research Database (NNRD)
II. Model impact of degrees of missing/inaccurate data on individually/cluster randomised neonatal trials
- Methods: Simulate multiple individually/cluster randomised neonatal trials using NNRD data; trial effect sizes/outcomes based on published trials
- Outcomes: rates of missing/inaccurate data required to alter modelled trial findings
3. Validate the extraction of core neonatal outcomes in the NNRD
I. Identify core neonatal outcomes (prioritised earlier in the fellowship) in the NNRD; formalise extraction; validate against published and existing trial data
- Methods: Analyses NNRD data; systematic review of reported rates in similar high resource settings and large neonatal trials
4. Realise learning from research placement in Boston Veteran's Affairs and Children's Hospitals
I. Disseminate qualitative data from research placement
II. Consensus meetings to identify acceptable integration of "Learning Healthcare System" approach into NHS neonatal care
Organisations
- Imperial College London (Lead Research Organisation)
- University of Nottingham (Collaboration)
- Örebro University (Collaboration)
- University of Oxford (Collaboration)
- London School of Hygiene and Tropical Medicine (LSHTM) (Collaboration)
- Murdoch Children's Research Institute (Collaboration)
- UNIVERSITY OF LIVERPOOL (Collaboration)
- Monash University (Collaboration)
People |
ORCID iD |
| Chris Gale (Principal Investigator / Fellow) |
Publications
Baba A
(2023)
Heterogeneity and Gaps in Reporting Primary Outcomes From Neonatal Trials
in Pediatrics
Baskaran D
(2023)
Kernicterus in neonates from ethnic minorities in the UK.
in Archives of disease in childhood. Fetal and neonatal edition
Branagan A
(2024)
Consensus definition and diagnostic criteria for neonatal encephalopathy-study protocol for a real-time modified delphi study.
in Pediatric research
Evans K
(2023)
National priority setting partnership using a Delphi consensus process to develop neonatal research questions suitable for practice-changing randomised trials in the UK.
in Archives of disease in childhood. Fetal and neonatal edition
Gong J
(2023)
Prevalence and risk factors for postnatal mental health problems in mothers of infants admitted to neonatal care: analysis of two population-based surveys in England.
in BMC pregnancy and childbirth
| Title | neoGASTRIC trial parent video |
| Description | Parent information video describing neoGASTRIC trial |
| Type Of Art | Film/Video/Animation |
| Year Produced | 2023 |
| Impact | Novel and innovative digital media to explain opt-out consent |
| URL | https://www.npeu.ox.ac.uk/neogastric/parents/neogastric-trial-video |
| Description | Expert Group Member: Enabling Safe, Quality Midwifery Services and Care in Northern Ireland. |
| Geographic Reach | Local/Municipal/Regional |
| Policy Influence Type | Contribution to a national consultation/review |
| URL | https://www.health-ni.gov.uk/news/department-commissions-new-report-midwifery-services-northern-irel... |
| Description | Expert witness - House of Lords Committee on Preterm Birth |
| Geographic Reach | National |
| Policy Influence Type | Contribution to a national consultation/review |
| URL | https://committees.parliament.uk/committee/701/preterm-birth-committee |
| Description | Accelerating the development of a perinatal platform trial to efficiently evaluate the effectiveness of multiple interventions in maternity and neonatal care |
| Amount | £199,592 (GBP) |
| Funding ID | NIHR156043 |
| Organisation | National Institute for Health and Care Research |
| Sector | Public |
| Country | United Kingdom |
| Start | 03/2023 |
| End | 02/2024 |
| Description | Better Outcomes in Babies with Bacterial meningitis |
| Amount | £5,900,000 (GBP) |
| Funding ID | NIHR166133 |
| Organisation | National Institute for Health and Care Research |
| Sector | Public |
| Country | United Kingdom |
| Start | 08/2025 |
| End | 09/2033 |
| Description | Health Technology Assessment |
| Amount | £2,400,000 (GBP) |
| Funding ID | NIHR134216 |
| Organisation | National Institute for Health and Care Research |
| Sector | Public |
| Country | United Kingdom |
| Start | 08/2022 |
| End | 09/2027 |
| Description | Measuring family spillover effects with EuroQol instruments over time |
| Amount | € 134,800 (EUR) |
| Organisation | EuroQol Group |
| Sector | Charity/Non Profit |
| Country | Netherlands |
| Start | 03/2025 |
| End | 03/2027 |
| Description | Meeting global need to improve newborn care through real-world-health-data-facilitated, digital-technology-supported randomised clinical trials |
| Amount | £656,698 (GBP) |
| Funding ID | MR/X009831/1 |
| Organisation | Medical Research Council (MRC) |
| Sector | Public |
| Country | United Kingdom |
| Start | 03/2023 |
| End | 03/2025 |
| Description | NHMRC-NIHR Collaborative Research Grant |
| Amount | $739,020 (AUD) |
| Funding ID | 2014792 |
| Organisation | National Health and Medical Research Council |
| Sector | Public |
| Country | Australia |
| Start | 08/2022 |
| End | 09/2027 |
| Description | Omeprazole for Treatment of Term and preterm infants with gastro-oEsophageal Reflux (OTTER) |
| Amount | £2,500,000 (GBP) |
| Organisation | National Institute for Health and Care Research |
| Sector | Public |
| Country | United Kingdom |
| Start | 03/2025 |
| End | 03/2028 |
| Description | Policy Research Unit in Maternal and Neonatal Health and Care |
| Amount | £5,500,000 (GBP) |
| Funding ID | NIHR206113 |
| Organisation | National Institute for Health and Care Research |
| Sector | Public |
| Country | United Kingdom |
| Start | 01/2024 |
| End | 12/2029 |
| Description | The Monoclonal Antibody Medications in inflammatory Arthritis: stopping or continuing in pregnancy (MAMA) trial |
| Amount | £3,100,000 (GBP) |
| Funding ID | NIHR153577 |
| Organisation | National Institute for Health and Care Research |
| Sector | Public |
| Country | United Kingdom |
| Start | 08/2023 |
| End | 08/2029 |
| Title | Measuring family spillover effects with EuroQol instruments over time |
| Description | The impact of neonatal care interventions on health outcomes affects not only the newborn but their mothers and other family members. These spillover effects are seldom included in economic evaluation of neonatal care technologies because data to evaluate these wider benefits are rarely collected. The ongoing withholding enteral feeds around blood transfusion (WHEAT) study is a multi-centre randomised controlled trial comparing withholding milk feeds before, during and after blood transfusion in preterm infants to reduce the risk of necrotising enterocolitis (NEC). An economic evaluation alongside the trial was not originally funded but investigators have now secured additional funding from the Bukhman Foundation to collect the relevant data for a cost analysis associated with NEC and an economic evaluation in the UK. In addition to resource use, planned data collection will include EQ-TIPS (for newborns), EQ-5D-5L (for parents), EQ-HWB (for parents) and EQ-5D-Y-3L (for siblings) at neonatal discharge, 6 months and 1 year follow-up. This longitudinal design will provide an excellent resource to understand whether EuroQol instruments used in the family context are able to capture spillover effects over time. |
| Type Of Material | Physiological assessment or outcome measure |
| Year Produced | 2020 |
| Provided To Others? | Yes |
| Impact | This research proposal provide a rare opportunity to understand whether the beta version of some of the EUROQOL Group's instruments (e.g. EQ-TIPS, EQ-5D)are fit for purpose to be used for the evaluation of family spillover effects. Conducting research in the family context of a baby with a neonatal condition is very expensive and it would be virtually impossible for the Group to support a study like this one in isolation. Our aim is to provide evidence that EuroQol instruments are able to capture family health spillover in the context of caring for a baby with NEC. If this is demonstrated, it will send an important signal to the scientific community as it will encourage the use of the instrument for the evaluation of spillover effects in the family context in future studies. |
| Title | Use of routinely recorded neonatal data in prospective randomised controlled trials |
| Description | I have pioneered the use of routinely recorded neonatal data held in the National Neonatal Research Database (NNRD) for prospective neonatal clinical trials through the WHEAT pilot trial, WHEAT trial and neoGASTRIC trials. This has reduced burden on clinical teams and has increased trial efficiency. Within the WHEAT pilot trial I have demonstrated the validity and accuracy of using routinely recorded data for trials in the neonatal context. |
| Type Of Material | Improvements to research infrastructure |
| Year Produced | 2021 |
| Provided To Others? | Yes |
| Impact | Increasing numbers of neonatal trials using the NNRD for some data capture (including BASE trial) |
| Description | Collaboration in developing a neonatal clinical trial using electronic health records |
| Organisation | London School of Hygiene and Tropical Medicine (LSHTM) |
| Department | Faculty of Epidemiology and Population Health |
| Country | United Kingdom |
| Sector | Academic/University |
| PI Contribution | Developed proposed neonatal nutrition clinical trial protocol. Undertaking feasibility study. Statistical expertise regarding trial design. Neonatal clinical trial expertise. |
| Collaborator Contribution | Regulatory expertise. Neonatal clinical expertise. Experience of running pragmatic, multi-centre neonatal clinical trials. Experience of running randomised clinical trials using electronic health records in general practice. |
| Impact | Protocol for proposed neonatal nutrition clinical trials using electronic health records NIHR HTA application for a proposed neonatal nutrition clinical trials using electronic health records |
| Start Year | 2014 |
| Description | Collaboration in developing a neonatal clinical trial using electronic health records |
| Organisation | University of Liverpool |
| Department | Department of Women's and Children's Health |
| Country | United Kingdom |
| Sector | Academic/University |
| PI Contribution | Developed proposed neonatal nutrition clinical trial protocol. Undertaking feasibility study. Statistical expertise regarding trial design. Neonatal clinical trial expertise. |
| Collaborator Contribution | Regulatory expertise. Neonatal clinical expertise. Experience of running pragmatic, multi-centre neonatal clinical trials. Experience of running randomised clinical trials using electronic health records in general practice. |
| Impact | Protocol for proposed neonatal nutrition clinical trials using electronic health records NIHR HTA application for a proposed neonatal nutrition clinical trials using electronic health records |
| Start Year | 2014 |
| Description | Collaboration in developing a neonatal clinical trial using electronic health records |
| Organisation | University of Nottingham |
| Department | Neonatal Medicine |
| Country | United Kingdom |
| Sector | Academic/University |
| PI Contribution | Developed proposed neonatal nutrition clinical trial protocol. Undertaking feasibility study. Statistical expertise regarding trial design. Neonatal clinical trial expertise. |
| Collaborator Contribution | Regulatory expertise. Neonatal clinical expertise. Experience of running pragmatic, multi-centre neonatal clinical trials. Experience of running randomised clinical trials using electronic health records in general practice. |
| Impact | Protocol for proposed neonatal nutrition clinical trials using electronic health records NIHR HTA application for a proposed neonatal nutrition clinical trials using electronic health records |
| Start Year | 2014 |
| Description | Developing Point-of-Care neonatal trials |
| Organisation | Örebro University |
| Country | Sweden |
| Sector | Academic/University |
| PI Contribution | Wider development and dissemination of point-of-care trial methodology developed at Orebro. |
| Collaborator Contribution | Intellectual input towards development of point-of-care trials |
| Impact | 1. Development of WHEAT randomised point-of-care trial 2. Input into the development of a European registry trial platform - initial meeting 23rd November 2015 |
| Start Year | 2014 |
| Description | International Perinatal Research (INPRES) Partnership |
| Organisation | Murdoch Children's Research Institute |
| Country | Australia |
| Sector | Academic/University |
| PI Contribution | The INPRES Partnership is a collaboration between institutions around the world, leading and undertaking research in the field of perinatology. I am leading the neoGASTRIC trial, the largest collaborative individually randomised neonatal trial yet undertaken and a key part of this collaboration |
| Collaborator Contribution | Within the INPRES collaboration we are undertaking a range of activities including prioritisation of research questions and other collaborative trial bids - these have been led by partner organisations |
| Impact | The James Lind Alliance (JLA) Priority Setting Partnership in the Most Premature Babies: in progress https://www.npeu.ox.ac.uk/most-premature-babies |
| Start Year | 2021 |
| Description | International Perinatal Research (INPRES) Partnership |
| Organisation | University of Oxford |
| Department | National Perinatal Epidemiology Unit Oxford |
| Country | United Kingdom |
| Sector | Academic/University |
| PI Contribution | The INPRES Partnership is a collaboration between institutions around the world, leading and undertaking research in the field of perinatology. I am leading the neoGASTRIC trial, the largest collaborative individually randomised neonatal trial yet undertaken and a key part of this collaboration |
| Collaborator Contribution | Within the INPRES collaboration we are undertaking a range of activities including prioritisation of research questions and other collaborative trial bids - these have been led by partner organisations |
| Impact | The James Lind Alliance (JLA) Priority Setting Partnership in the Most Premature Babies: in progress https://www.npeu.ox.ac.uk/most-premature-babies |
| Start Year | 2021 |
| Description | Process evaluation within neonatal clinical trials |
| Organisation | University of Liverpool |
| Department | School of Life Sciences Liverpool |
| Country | United Kingdom |
| Sector | Academic/University |
| PI Contribution | We have developed a strong collaborative relationship with the trial process evaluation group based at the University of Liverpool, this has led to funding for embedded process evaluation within the neoGASTRIC trial and has informed trial processes. This has further developed opt-out consent for neonatal trials and evaluated it internationally. |
| Collaborator Contribution | The partner organisation have led the process evaluation methodology which has been embedded into the trial. |
| Impact | No outcomes as yet |
| Start Year | 2023 |
| Description | neoGASTRIC trial Australia |
| Organisation | Monash University |
| Country | Australia |
| Sector | Academic/University |
| PI Contribution | Developed a multicentre clinical trial to run in Australia and the UK - this will be the largest individually randomised neonatal clinical trial ever undertaken |
| Collaborator Contribution | Led collaboration, led development of trial protocol, built collaborating team |
| Impact | Multidisciplinary collaboration including: clinical academics, nurses, statisticians, health economists, parents |
| Start Year | 2021 |
| Title | Routine measurement of gastric residual volumes |
| Description | Largest preterm individually randomised trial internationally, currently underway - recruiting ahead of time and target |
| Type | Therapeutic Intervention - Psychological/Behavioural |
| Current Stage Of Development | Late clinical evaluation |
| Year Development Stage Completed | 2025 |
| Development Status | Under active development/distribution |
| Clinical Trial? | Yes |
| Impact | Utilising and evaluating a novel approach to consent and recruitment in clinical trial - op-out consent for comparative effectiveness, low additional risk trials. |
| Description | 'Opt-out consent and Platform trials' podcast with Prof Tony Gordon |
| Form Of Engagement Activity | A broadcast e.g. TV/radio/film/podcast (other than news/press) |
| Part Of Official Scheme? | No |
| Geographic Reach | International |
| Primary Audience | Professional Practitioners |
| Results and Impact | PicPod podcast where features, challenges and advantages of opt-out consent and platform trials were discussed. |
| Year(s) Of Engagement Activity | 2022 |
| URL | https://picpod.net/ |